Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Apyx Medical (APYX) Receivables - Net (2016 - 2026)

Apyx Medical filings provide 16 years of Receivables - Net readings, the most recent being $16.8 million for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 8.37% to $16.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.8 million, a 8.37% increase, with the full-year FY2025 number at $16.8 million, up 8.37% from a year prior.
  • Receivables - Net hit $16.8 million in Q4 2025 for Apyx Medical, up from $13.0 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $16.8 million in Q4 2025 to a low of $7.7 million in Q1 2021.
  • Median Receivables - Net over the past 5 years was $12.2 million (2022), compared with a mean of $11.9 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 85.96% in 2021 and later fell 20.53% in 2022.
  • Apyx Medical's Receivables - Net stood at $13.0 million in 2021, then dropped by 18.68% to $10.6 million in 2022, then surged by 32.27% to $14.0 million in 2023, then rose by 10.39% to $15.5 million in 2024, then increased by 8.37% to $16.8 million in 2025.
  • The last three reported values for Receivables - Net were $16.8 million (Q4 2025), $13.0 million (Q3 2025), and $11.2 million (Q2 2025) per Business Quant data.